US Growth Companies With High Insider Ownership In January 2025

In This Article:

As the U.S. markets continue to rally, buoyed by President Trump's recent executive actions and a positive economic outlook, investors are increasingly focused on growth companies with solid fundamentals. In this environment, stocks with high insider ownership can be particularly appealing as they often signal confidence from those closest to the company's operations and strategic direction.

Top 10 Growth Companies With High Insider Ownership In The United States

Name

Insider Ownership

Earnings Growth

Atour Lifestyle Holdings (NasdaqGS:ATAT)

26%

25.6%

Super Micro Computer (NasdaqGS:SMCI)

14.4%

24.3%

On Holding (NYSE:ONON)

19.1%

29.8%

Kingstone Companies (NasdaqCM:KINS)

20.8%

24.9%

Clene (NasdaqCM:CLNN)

21.6%

59.1%

BBB Foods (NYSE:TBBB)

22.9%

41%

Credit Acceptance (NasdaqGS:CACC)

14.1%

48%

Smith Micro Software (NasdaqCM:SMSI)

23.1%

85.4%

CarGurus (NasdaqGS:CARG)

16.9%

42.4%

Similarweb (NYSE:SMWB)

25.4%

126.3%

Click here to see the full list of 206 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Let's dive into some prime choices out of the screener.

Krystal Biotech

Simply Wall St Growth Rating: ★★★★★☆

Overview: Krystal Biotech, Inc. is a commercial-stage biotechnology company focused on discovering, developing, and commercializing genetic medicines for rare diseases in the United States, with a market cap of approximately $4.27 billion.

Operations: The company's revenue is derived from its business of developing and commercializing pharmaceuticals, amounting to $241.52 million.

Insider Ownership: 10.4%

Earnings Growth Forecast: 36.6% p.a.

Krystal Biotech is trading significantly below its estimated fair value, with earnings projected to grow substantially at 36.6% annually, outpacing the US market. The company recently reported promising clinical results from its KYANITE-1 study for lung cancer treatment and continues advancing its genetic medicine programs. Despite a recent dip in quarterly net income to US$27.18 million, Krystal's innovative therapies like VYJUVEK® highlight strong growth potential amidst high insider ownership.

NasdaqGS:KRYS Earnings and Revenue Growth as at Jan 2025
NasdaqGS:KRYS Earnings and Revenue Growth as at Jan 2025

VNET Group

Simply Wall St Growth Rating: ★★★★☆☆

Overview: VNET Group, Inc. is an investment holding company that offers hosting and related services in China, with a market cap of approximately $1.50 billion.

Operations: The company's revenue is primarily derived from hosting and related services, totaling CN¥7.91 billion.